[1]
Jayasaputra, M. et al. 2016. Mesothelin versus Ca125 in Screening the Ovarian Malignancy. Indonesian Journal of Obstetrics and Gynecology. 4, 2 (Apr. 2016), 107–110. DOI:https://doi.org/10.32771/inajog.v4i2.85.